Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CEO Jeremy Be

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 7,873 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $16.08, for a total transaction of $126,597.84. Following the completion of the sale, the chief executive officer now […]

Related Keywords

Timessquare , New York , United States , Piper Sandler , Jeremy Bender , York Mellon Corp , Vanguard Group Inc , Goldman Sachs Group , York State Common Retirement Fund , Timessquare Capital Management , Needham Company , Nasdaq , Day One Biopharmaceuticals Company Profile , Charles Schwab Investment Management Inc , Day One Biopharmaceuticals Inc , Day One Biopharmaceuticals , Get Free Report , One Biopharmaceuticals , Schwab Investment Management , New York Mellon Corp , Square Capital Management , Day One Biopharmaceuticals Daily ,